来自专业的译者、企业、网页和免费的翻译库。
investigation of plasma derived
investigation of plasma derived antithrombin products
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
core spc for human plasma derived
core spc for human plasma derived
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
core spc for human plasma derived antithrombin
stato adottato nel gennaio 2002
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
note for guidance on plasma- derived medicinal products
note for guidance on plasma-derived medicinal products
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
clinical investigation of plasma derived factor viii and ix products
clinical investigation of plasma derived factor viii and ix products
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
addendum to note for guidance on plasma- derived medicinal products
addendum to note for guidance on plasma-derived medicinal products
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
core spc for human plasma derived and recombinant coagulation factor ix products
core spc for human plasma derived and recombinant coagulation factor ix products
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
Τίτλος εγγράφου note for guidance on the clinical investigation of plasma derived antithrombin products
titolo del documento note for guidance on the clinical investigation of plasma derived antithrombin products
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
immunoglobulin for intravenous administration (ivig) core spc for human plasma derived and
immunoglobulin for intravenous administration (ivig) core spc for human plasma derived and
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
concept paper on the development of a cpmp guideline on comparability of biotechnology- derived products
documento concettuale concept paper on gene therapy concept paper on the development of a cpmp guideline on comparability of biotechnology-derived products
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
the expiry date of products incorporating plasma- derived products as stabilisers or excipients:
the expiry date of products incorporating plasma-derived products as stabilisers or excipients:
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
cpmp/ bwp/ 201/ 98 new variant cjd and plasma- derived medicinal products
numero di riferimento cpmp/ bwp/ 201/ 98
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
biotechnology- derived proteins as active substances position statement on the use of tumorigenic cells of human origin for the
medicinal products containing biotechnology-derived proteins as active substances position statement on the use of tumorigenic cells of human origin for the
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
human tses and plasma- derived medicinal products, 15- 16 may 2000 concept paper on the development of a
human tses and plasma-derived medicinal products, 15-16 maggio 2000 concept paper on the development of a
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
Τίτλος εγγράφου note for guidance on the clinical investigation of plasma derived fibrin sealants note for guidance on the clinical investigation of von willebrand factor warning on transmissible agents for patient leaflets and spcs core spc for plasma derived fibrin sealants
titolo del documento note for guidance on the clinical investigation of plasma derived fibrin sealants note for guidance on the clinical investigation of von willebrand factor warning on transmissible agents for patient leaflets and spcs core spc for plasma derived fibrin sealants
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
contribution to part s. 2. 3 of the structure of the dossier for applications for marketing authorisation – control of starting materials for the production of plasma- derived medicinal products
contribution to part s.2.3 of the structure of the dossier for applications for marketing authorisation – control of starting materials for the production of plasma-derived medicinal products
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
ΠΡΟΣΟΧΗ: Η υποστήριξη 48-bit lba atapi είναι απενεργοποιημένη στο σύστημα σας. Γι' αυτό δε θα πρέπει να γράψετε σε δίσκους ide μεγαλύτερους από 128 gb! Αν το κάνετε, δεδομένα του δίσκου (άσχετα αν είναι τόμου truecrypt) μπορεί να αλλοιωθούν. Σημειώστε ότι αυτός είναι ένας περιορισμός των windows, όχι ελάττωμα του truecrypt.Για να ενεργοποιήσετε την υποστήριξη 48-bit lba, προσθέστε την τιμή enablebiglba στο κλειδί του μητρώου hkey_local_machine\\system\\currentcontrolset\\services\\atapi\\parameters και ορίστε την 1.Περισσότερες πληροφορίες στη http://support.microsoft.com/kb/305098
attenzione: il supporto lba atapi a 48 bit è disabilitato su questo sistema. e' sconsigliato scrivere su dischi ide più grandi di 128 gb! in caso contrario, i dati sul disco (non importa se si tratta di un volume truecrypt o no) potrebbero essere corrotti. questa è una limitazione di windows, non un bug di truecrypt.per abilitare il supporto lba a 48 bit, aggiungere il valore 'enablebiglba' nella chiave di registro hkey_local_machine\\system\\currentcontrolset\\services\\atapi\\parameters e impostarlo a 1.per maggiori informazioni si veda http://support.microsoft.com/kb/305098
最后更新: 2012-08-05
使用频率: 1
质量: